Atlantic Edge Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
RG
ECSS
LT
ATO
QP
Atlantic Edge Private Wealth Management's TMO Position: Q2 2026 in Review
Atlantic Edge Private Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, selling an estimated $678K and leaving 4,833 shares worth $2.42M. The position accounts for 0.5% of the portfolio, ranked #47.
Atlantic Edge Private Wealth Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.64M in Q4 2025. 966 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Atlantic Edge Private Wealth Management held 4,833 shares of Thermo Fisher Scientific worth $2.42M as of Q2 2026.
- Atlantic Edge Private Wealth Management sold 1,413 Thermo Fisher Scientific shares in Q2 2026, an estimated $678K.
- Thermo Fisher Scientific made up 0.5% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #47 holding.
- Atlantic Edge Private Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
- Atlantic Edge Private Wealth Management's Thermo Fisher Scientific position peaked at $3.64M in Q4 2025.
- 966 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.